Pfizer Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Pfizer Limited
Symbol
PFIZER
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Not Applicable
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Not Applicable
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
30-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.pfizerltd.co.in/financial-information
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.pfizerltd.co.in/newspaper-advertisements
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.pfizerltd.co.in/files/pfizer_limited_dividend_distribution_policy.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.pfizerltd.co.in/files/Policy-on-criteria-for-determining-Materiality-of-Events.pdf
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.pfizerltd.co.in/about-pfizer
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.pfizerltd.co.in/whistle-blower-vigil-mechanism
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.pfizerltd.co.in/financial-information
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.pfizerltd.co.in/files/Related-Party-Transaction-Policy_feb-2022.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.pfizerltd.co.in/shareholding-pattern
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.pfizerltd.co.in/investor-relations
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.pfizerltd.co.in/investor-relations
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.pfizerltd.co.in/files/Contact-details-of-KMP-who-are-authorized-for-the-purpose-of-determining-materiality.pdf
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.pfizerltd.co.in/statutory-communications-2024-2025
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.pfizerltd.co.in/files/Pfizer-Limited_MOA-AOA.pdf
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.pfizerltd.co.in/statutory-communications-2025-2026
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE182A01018
Market Capitalisation As Per Immediate Previous Financial Year
Top 500 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Prajeet Nair
Name Of Signatory Affirmations
Prajeet Nair
Name Of Signatory For Annual Affirmations
Prajeet Nair
Name Of Signatory For Quartely Affirmations
Prajeet Nair
Name Of The Company
Pfizer Limited
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Not Applicable
Place
Mumbai
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Not Applicable
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
Not Applicable
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Not Applicable
SCORES Registration ID
p00107
Scrip Code
500680
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Not Applicable
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
PFIZER
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Not Applicable
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

Disclosure Of Notes On Composition Of Board Of Directors Explanatory Text Block
1.Mr. Pradip Shah was appointed as a Non-Executive Non-Independent Director with effect from November 10, 2024, liable to retire by rotation. 2.Ms. Meena Ganesh was re-appointed as an Independent Director with effect from March 8, 2024, for her second term of 5 years. 3.Mr. Lakshmanan Krishnakumar and Ms. Sonia Singh were appointed as Independent Directors with effect from July 29, 2024, for a term of 5 years. 4.Ms. Meenakshi Nevatia was appointed as Managing Director of the Company with effect from April 3, 2023. 5.Mr. P. Rengan was appointed as an Execute Director Plant Operations with effect from October 28, 2023, for a term of 5 years. 6.Mr. Amit Agarwal was appointed as an Executive Director Finance with effect from February 26, 2024, for a term of 5 years.
The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrPradip Shah******00066242Non-Executive - Non Independent DirectorChairperson07-Jan-1953NoActiveNot Applicable10-Nov-202410-Nov-202415.214272
2MsMeena Ganesh******00528252Non-Executive - Independent DirectorNot Applicable31-Aug-1963NoActiveNot Applicable08-Mar-201908-Mar-202484.245572
3MrLakshmanan Krishnakumar******00423616Non-Executive - Independent DirectorNot Applicable29-Oct-1958NoActiveNot Applicable29-Jul-202429-Jul-202420.031143
4MsSonia Singh******07108778Non-Executive - Independent DirectorNot Applicable05-Sep-1964NoActiveNot Applicable29-Jul-202429-Jul-202420.035552
5MsMeenakshi Nevatia******08235844Executive DirectorNot ApplicableCEO-MD23-Feb-1971NoActiveNot Applicable03-Apr-202303-Apr-202302120
6MrAmit Agarwal******10465938Executive DirectorNot Applicable18-Jan-1981NoActiveNot Applicable26-Feb-202426-Feb-202401000
7MrP Rengan******10362899Executive DirectorNot Applicable23-Aug-1977NoActiveNot Applicable28-Oct-202328-Oct-202301010

Committee Disclosures

Entry CompComit122
Date of Appointment
02-May-2014
Entry CompComit123
Date of Appointment
29-Jul-2024
Entry CompComit124
Date of Appointment
03-Apr-2023
Entry CompComit125
Date of Appointment
26-Feb-2024
Entry CompComit126
Date of Appointment
28-Oct-2023
Entry CompComit14
Date of Appointment
29-Jul-2024
Entry CompComit15
Date of Appointment
07-Dec-2000
Entry CompComit16
Date of Appointment
29-Jul-2024
Entry CompComit41
Date of Appointment
03-Feb-2022
Entry CompComit42
Date of Appointment
28-Apr-2014
Entry CompComit43
Date of Appointment
29-Jul-2024
Entry CompComit44
Date of Appointment
29-Jul-2024
Entry CompComit68
Date of Appointment
29-Jul-2024
Entry CompComit69
Date of Appointment
29-Jul-2024
Entry CompComit70
Date of Appointment
13-Sep-2023
Entry CompComit71
Date of Appointment
28-Oct-2023
Entry CompComit95
Date of Appointment
29-Jul-2024
Entry CompComit96
Date of Appointment
08-Mar-2019
Entry CompComit97
Date of Appointment
03-Apr-2023
Entry CompComit98
Date of Appointment
26-Feb-2024
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.pfizerltd.co.in/our-people/board-of-directors
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
00423616
Member Name
Lakshmanan Krishnakumar
Notes
Mr. L. Krishnakumar was appointed as the Chairman of the Committee with effect from November 10, 2024.
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00066242
Member Name
Pradip Shah
Position
Non-Executive - Non Independent Director

Audit Committee

Additional Position
Member
Director DIN
00528252
Member Name
Meena Ganesh
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
00066242
Member Name
Pradip Shah
Position
Non-Executive - Non Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
07108778
Member Name
Sonia Singh
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
08235844
Member Name
Meenakshi Nevatia
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
10465938
Member Name
Amit Agarwal
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
10362899
Member Name
P Rengan
Position
Executive Director

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00528252
Member Name
Meena Ganesh
Notes
Ms. Meena Ganesh was appointed as the Chairperson of the Nomination and Remuneration Committee effective November 10, 2024.
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00066242
Member Name
Pradip Shah
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00423616
Member Name
Lakshmanan Krishnakumar
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
07108778
Member Name
Sonia Singh
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Other Committee

Additional Position
Chairperson
Director DIN
08235844
Member Name
Meenakshi Nevatia
Name Of Other Committee
Board Administrative and Share Transfer Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
10465938
Member Name
Amit Agarwal
Name Of Other Committee
Board Administrative and Share Transfer Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
10362899
Member Name
P Rengan
Name Of Other Committee
Board Administrative and Share Transfer Committee
Position
Executive Director

Risk Management Committee

Additional Position
Chairperson
Director DIN
07108778
Member Name
Sonia Singh
Notes
Ms. Sonia Singh was appointed as the Chairperson of the Risk Management Committee effective February 14, 2025.
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
00528252
Member Name
Meena Ganesh
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
08235844
Member Name
Meenakshi Nevatia
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
10465938
Member Name
Amit Agarwal
Position
Executive Director

Risk Management Committee

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00528252
Member Name
Meena Ganesh
Notes
Ms. Meena Ganesh was appointed as the Chairperson of the Stakeholders' Relationship Committee effective February 14, 2025.
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00423616
Member Name
Lakshmanan Krishnakumar
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
08235844
Member Name
Meenakshi Nevatia
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
10362899
Member Name
P Rengan
Position
Executive Director

Stakeholders Relationship Committee

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
12-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
7
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
09-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
88
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
7
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
12-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
09-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
88
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Previous Quarter
13-Aug-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
09-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
179
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Previous Quarter
19-May-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
09-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
265
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Previous Quarter
31-Jan-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
5
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
5
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Relevant Quarter
09-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
373
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.pfizerltd.co.in/investor-grievance-redressal
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.pfizerltd.co.in/investor-grievance-redressal
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
10
No Of Investor Complaints During The Period
-2
No Of Investor Complaints Received During The Period
8
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
2
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Not Applicable
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
The company has not acquired any shares or voting rights in any unlisted company during the quarter and hence, Annexure I Part C of the SEBI circular dated Decemebr 31, 2024 is not applicable.
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The matter is pending before Hon'ble High Court of Bombay.
Date of Initiation
31-Jan-2018
Opposing Party
Deputy Commissioner of Income Tax
Status (Previous Disclosure)
The dispute against the tax demand of Rs.98.45 crores (including interest) on disallowance of depreciation and certain expenses for FY 2014-15 was pending before Hon'ble High Court of Bombay.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
The matter is pending before Hon'ble High Court of Bombay.
Date of Initiation
02-Feb-2017
Opposing Party
Deputy Commissioner of Income Tax
Status (Previous Disclosure)
The dispute against the tax demand of Rs.80.05 crores (including interest) on disallowance of depreciation and certain expenses for FY 2013-14 was pending before Hon'ble High Court of Bombay.
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
The matter is pending before Hon'ble High Court of Bombay.
Date of Initiation
18-Jan-2019
Opposing Party
Deputy Commissioner of Income Tax
Status (Previous Disclosure)
The dispute against the tax demand of Rs.61.31 crores (including interest) on disallowance of depreciation and certain expenses for FY 2015-16 was pending before Hon'ble High Court of Bombay.
Entry I_OngoingTaxLitigationsOrDisputes4
Current Status
Both the appeals before the Commissioner of Income Tax are pending . ITAT has allowed the Company to withdraw appeal with a liberty to approach again in case of unfavourable order from lower appellate authority and hon'ble Bombay High Court has granted a stay till appeal before ITAT is decided.
Date of Initiation
24-Jan-2020
Opposing Party
Assistant Commissioner of Income Tax
Status (Previous Disclosure)
(1) The dispute against tax demand of Rs.44.25 crores raised due to disallowance of depreciation and certain expenses in assessment under section 143(3) for FY 2016-17 was pending before Commissioner of Income Tax (Appeals). (2) Writ filed by the Company is disposed off by Hon'ble High Court against order under section 143(3) giving effect to the order of the Principal Commissioner under section 263 with incremental tax effect of Rs.12.69 crores having been passed beyond the statutory timelines by asking us to approach lower authorities. And accordingly company has filed an appeal with CIT(A) against such order with a limited ground of validity of such order. (3)Further, re-characterization of short term capital gains proposed by Principal Commissioner of Income Tax in proceedings under section 263 was challenged before the Income Tax Appellate Tribunal has now been withdrawn by company as per directives of High Court, with a liberty to approach Tribunal again in case of adverse order from lower authorities.
Entry I_OngoingTaxLitigationsOrDisputes5
Current Status
The matter is pending before the Commissioner of Income Tax (Appeals).
Date of Initiation
25-Oct-2023
Opposing Party
Assessment Unit, Income tax department
Status (Previous Disclosure)
The dispute against the tax demand of Rs.32.40 crores (including interest) on disallowance of depreciation and certain expenses for FY 2019-20 was pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes6
Current Status
The matter is pending before Hon'ble High Court of Bombay.
Date of Initiation
10-Dec-2018
Opposing Party
National Pharmaceutical Pricing Authority
Status (Previous Disclosure)
Writ petition filed with the Hon'ble High Court of Bombay against the demand of Rs. 48.46 crore raised by NPPA alleging price increase in excess of permissible limit for the period April 2015 to August 2017.
Entry I_OngoingTaxLitigationsOrDisputes7
Current Status
The matter is pending before Hon'ble High Court of Bombay.
Date of Initiation
28-Jan-2008
Opposing Party
National Pharmaceutical Pricing Authority
Status (Previous Disclosure)
Writ petition is filed with the Hon'ble High Court of Bombay against the alleged demand of Rs. 45.09 crore raised by NPPA in 2007 in respect of 6 bulk drugs & formulations thereof.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
During the quarter ended March 31, 2026, no fines or penalties were imposed on the Company which are to be disclosed as per Part D of the SEBI circular dated December 31, 2024.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No